Skip to main content
. 2020 Dec 3;11:593506. doi: 10.3389/fphar.2020.593506

FIGURE 3.

FIGURE 3

Anti-inflammatory activity of several concentrations of CLJ evaluated by BSA denaturation (A) and anti-protease activity (B) assays. Diclofenac sodium (50 and 80 µg/ml, respectively) was used as reference compound in both assays. Results were expressed as mean inhibition percentage ± standard deviation of three independent experiments (n = 3). *p < 0.01 vs positive control (CTR+).